Protein Science
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DELA-CADENA, R. A.
Right arrow Articles by COLMAN, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DELA-CADENA, R. A.
Right arrow Articles by COLMAN, R. W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Protein Science, Vol 1, Issue 1 151-160, Copyright © 1992 by Cold Spring Harbor Laboratory Press


ARTICLE

The sequence HGLGHGHEQQHGLGHGH in the light chain of high molecular weight kininogen serves as a primary structural feature for zinc-dependent binding to an anionic surface

R. A. DELA-CADENA and R. W. COLMAN
Thrombosis Research Center

The histidine-glycine-rich region of the light chain of cleaved high molecular weight kininogen (HK) is thought to be responsible for binding to negatively charged surfaces and initiation of the intrinsic coagulation, fibrinolytic, and kinin-forming systems. However, the specifically required amino acid sequences have not been delineated. An IgG fraction of a monoclonal antibody (MAb) C11C1 to the HK light chain was shown to inhibit by 66% the coagulant activity and by 57% the binding of HK to the anionic surface of kaolin at a concentration of 1.5 {mu}M and 27 {mu}M, respectively. Proteolytic fragments of HK were produced by successive digestion with human plasma kallikrein and factor XIa (FXIa). Those polypeptides that bound tightly (K(d) = 0.77 nM) to a C11C1 affinity column were eluted at pH 3.0 and purified by membrane filtration. On 15% SDS polyacrylamide electrophoresis, the approximate M(r) was 7.3 kDa (range 6.2-8.1 kDa). Based on N-terminal sequencing, this polypeptide (l(2)), which extends from the histidine residue 459 to a lysine at position 505, 509, 511, 512, 515, or 520, inhibits by 50% the coagulant activity expressed by HK at a concentration of 22 {mu}M. The synthetic peptide HGLGHGH representing the N-terminal of the l(2) fragment was synthesized, tested, and found at 4 mM to inhibit the procoagulant activity of HK 50%. A synthetic heptadecapeptide, HGLGHGHEQQHGLGHGH (residues 459-475) included within the l(2) fragment, and with the ability to bind zinc, inhibited 50% of the HK coagulant activity at a concentration of 325 {mu}M in the absence and presence of added Zn(2+) (30 {mu}M). The specific binding of (125)I-HK to a negatively charged surface (kaolin) was inhibited 50% by unlabeled HK (5 {mu}M). HGLGHGH, at a concentration of 7.0 mM, inhibited the binding to kaolin by 50%. The heptadecapeptide inhibited the specific binding of (125)I-HK to kaolin by 50%, at a concentration of 2.3 mM, in the absence of Zn(2+). In contrast, when Zn(2+) was added, the concentration to achieve 50% inhibition decreased to 630 {mu}M, indicating that Zn(2+) was required to attain a favorable conformation for binding. Moreover, the l(2) fragment was found to inhibit 50% of the (125)I-HK binding to kaolin at a concentration of 380 {mu}M. These results suggest that residues contained within the l(2) fragment, notably NGLGHGHEQQHGLGHGH, serves as a primary structural feature for binding to a negatively charged surface.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. M. Khan, H. N. Bradford, I. Isordia-Salas, Y. Liu, Y. Wu, R. G. Espinola, B. Ghebrehiwet, and R. W. Colman
High-Molecular-Weight Kininogen Fragments Stimulate the Secretion of Cytokines and Chemokines Through uPAR, Mac-1, and gC1qR in Monocytes
Arterioscler. Thromb. Vasc. Biol., October 1, 2006; 26(10): 2260 - 2266.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. A. Nordahl, V. Rydengard, M. Morgelin, and A. Schmidtchen
Domain 5 of High Molecular Weight Kininogen Is Antibacterial
J. Biol. Chem., October 14, 2005; 280(41): 34832 - 34839.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
N. Kato, T. Okayama, H. Isawa, M. Yuda, Y. Chinzei, and S. Iwanaga
Contribution of the N-Terminal and C-Terminal Domains of Haemaphysalin to Inhibition of Activation of Plasma Kallikrein-Kinin System
J. Biochem., September 1, 2005; 138(3): 225 - 235.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. S. Song, I. M. Sainz, S. C. Cosenza, I. Isordia-Salas, A. Bior, H. N. Bradford, Y.-L. Guo, R. A. Pixley, E. P. Reddy, and R. W. Colman
Inhibition of tumor angiogenesis in vivo by a monoclonal antibody targeted to domain 5 of high molecular weight kininogen
Blood, October 1, 2004; 104(7): 2065 - 2072.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. G. Espinola, A. Uknis, I. M. Sainz, I. Isordia-Salas, R. Pixley, R. DeLa Cadena, W. Long, A. Agelan, J. Gaughan, A. Adam, et al.
A Monoclonal Antibody to High-Molecular Weight Kininogen Is Therapeutic in a Rodent Model of Reactive Arthritis
Am. J. Pathol., September 1, 2004; 165(3): 969 - 976.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Chavakis, R. A. Pixley, I. Isordia-Salas, R. W. Colman, and K. T. Preissner
A Novel Antithrombotic Role for High Molecular Weight Kininogen as Inhibitor of Plasminogen Activator Inhibitor-1 Function
J. Biol. Chem., August 30, 2002; 277(36): 32677 - 32682.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Isawa, M. Yuda, Y. Orito, and Y. Chinzei
A Mosquito Salivary Protein Inhibits Activation of the Plasma Contact System by Binding to Factor XII and High Molecular Weight Kininogen
J. Biol. Chem., July 26, 2002; 277(31): 27651 - 27658.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Chavakis, N. Boeckel, S. Santoso, R. Voss, I. Isordia-Salas, R. A. Pixley, E. Morgenstern, R. W. Colman, and K. T. Preissner
Inhibition of Platelet Adhesion and Aggregation by a Defined Region (Gly-486-Lys-502) of High Molecular Weight Kininogen
J. Biol. Chem., June 21, 2002; 277(26): 23157 - 23164.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
T. CHAVAKIS, S. M. KANSE, R. A. PIXLEY, A. E. MAY, I. ISORDIA-SALAS, R. W. COLMAN, and K. T. PREISSNER
Regulation of leukocyte recruitment by polypeptides derived from high molecular weight kininogen
FASEB J, November 1, 2001; 15(13): 2365 - 2376.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
E. Mattsson, H. Herwald, H. Cramer, K. Persson, U. Sjobring, and L. Bjorck
Staphylococcus aureus Induces Release of Bradykinin in Human Plasma
Infect. Immun., June 1, 2001; 69(6): 3877 - 3882.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Zhao, Q. Qiu, F. Mahdi, Z. Shariat-Madar, R. Rojkjar, and A. H. Schmaier
Assembly and activation of HK-PK complex on endothelial cells results in bradykinin liberation and NO formation
Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1821 - H1829.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Chavakis, S. M. Kanse, F. Lupu, H.-P. Hammes, W. Muller-Esterl, R. A. Pixley, R. W. Colman, and K. T. Preissner
Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor-dependent interactions
Blood, July 15, 2000; 96(2): 514 - 522.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. W. Colman, B. A. Jameson, Y. Lin, D. Johnson, and S. A. Mousa
Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis
Blood, January 15, 2000; 95(2): 543 - 550.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L.-Y. L. Yung, R. W. Colman, and S. L. Cooper
Neutrophil Adhesion on Polyurethanes Preadsorbed With High Molecular Weight Kininogen
Blood, October 15, 1999; 94(8): 2716 - 2724.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. M. H. Khan, S. P. Kunapuli, Y. Lin, A. Majluf-Cruz, R. A. D. Cadena, S. L. Cooper, and R. W. Colman
Three noncontiguous peptides comprise binding sites on high-molecular-weight kininogen to neutrophils
Am J Physiol Heart Circ Physiol, July 1, 1998; 275(1): H145 - H150.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X.-X. Qin, K. J. Coyne, and J. H. Waite
Tough Tendons. MUSSEL BYSSUS HAS COLLAGEN WITH SILK-LIKE DOMAINS
J. Biol. Chem., December 19, 1997; 272(51): 32623 - 32627.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. W. Colman and A. H. Schmaier
Contact System: A Vascular Biology Modulator With Anticoagulant, Profibrinolytic, Antiadhesive, and Proinflammatory Attributes
Blood, November 15, 1997; 90(10): 3819 - 3843.
[Full Text] [PDF]


Home page
ScienceHome page
K. J. Coyne, X. Qin, and J. H. Waite
Extensible Collagen in Mussel Byssus: A Natural Block Copolymer
Science, September 19, 1997; 277(5333): 1830 - 1832.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. A. K. Hasan, D. B. Cines, H. Herwald, A. H. Schmaier, and W. Müller-Esterl
Mapping the Cell Binding Site on High Molecular Weight Kininogen Domain 5
J. Biol. Chem., August 18, 1995; 270(33): 19256 - 19261.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. H. Ho, K. Badellino, F. A. Baglia, M.-F. Sun, M.-M. Zhao, D. Gailani, and P. N. Walsh
The Role of High Molecular Weight Kininogen and Prothrombin as Cofactors in the Binding of Factor XI A3 Domain to the Platelet Surface
J. Biol. Chem., August 11, 2000; 275(33): 25139 - 25145.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by The Protein Society.